15 Jersikas street, Riga, LV-1003, Latvia
Phones: +371-67078424
Mob.: +371-29447659
Fax: +371-67078428
e-mail:
All contacts

Facebook: Zāļu valsts aģentūra Twitter: Zāļu valsts aģentūra LinkedIn: Zāļu valsts aģentūra
  
News About Us Legislation Services Publications Feedback and
Questions
Register
April 23, 2014
  lv en 

SAM has released the fourth "Cito!" edition of 2013

Read more

"Cito!" is available at the State Agency of Medicines (Jersikas street 15, Riga), in Room 11

SAM has issued the 2013 Drug Register!

Read more
Read more about the Drug Register

SAM has issued the Annual Report 2012

Read more

SAM has issued the 2012 Statistics on Medicines Consumption

Read more

SAM has issued the Good Clinical Practice

Read more
Read more about this publication

News
print print  

March 7, 2014  


 

Information for marketing authorisation holders

The State Agency of Medicines informs that from now the product information (summary of product characteristics, package leaflet and labeling text) in the Medicinal Product Register on SAM website will be published in Word format that will facilitate its use for marketing authorisation holders. Product information in Word format will be available from March 5, 2014, starting with medicinal products included in the Order Regarding Marketing Authorisation of Medicinal Products No 2-20/20 (05.03.2014.). The format of documents published previously will not be changed.

 

March 6, 2014  


 

The market value of products made by local manufacturers in 2013 - almost 150 million euros

During the previous year medicinal product manufacturers in Latvia have manufactured products (medicines and other goods) worth 104 million lats (149 mil. euros), which is 3% less than in 2012. The majority (90.4%) of the manufactured products were exported to other countries, but 9.6% were distributed in the local market. Read more

 

March 5, 2014  


 

The State Agency of Medicines increases the number of various e-permits

The State Agency of Medicines informs that it has initiated the issuance of electronic documents (permits, authorisations etc.) as laid down in the normative acts of the Republic of Latvia*. Read more

 

February 4, 2014  


 

Award presented for reporting of adverse drug reactions

Annual Award in Medicine 2013

In the ceremony of the Annual Award in Medicine 2013 organized by the Latvian Physicians Association on January 31st, 2014, the Director of the State Agency of Medicines (hereinafter also - SAM) Inguna Adovica presented an award for ethical behavior and significant contribution in reporting of adverse drug reactions to the Talsi Hospital and its Head Physician Brigita Aispure. Read more

 

December 12, 2013  


 

Baltic Statistics on Medicines Published

“Baltic Statistics on Medicines 2010-2012” is a statistical summary of the medicines consumption data of the Baltic countries over the last three years. The description of the reimbursement systems, an overview of the medicinal products market and other related subjects can be found in the publication as well.

The national consumption statistics have been collected and published annually in all the Baltic countries for several years but this is the first joint publication which provides comparative data illustrating the differences and similarities of the consumption of drugs in our countries. Read more

 

November 15, 2013  


 

From November 18th, 2013, Latvia will ensure submission of marketing authorisation documentation of medicinal products in the Common European Submission Platform (CESP)

The State Agency of Medicines (hereinafter - Agency) informs that starting from November 18th, 2013, the Agency will join the Common European Submission Platform (CESP) for submission of marketing authorisation documentation of medicines. In the portal Agency clients will be able to submit marketing authorisation documentation of medicines simultaneously to all the chosen medicines agencies of European Union (hereinafter - EU) member states. Read more

 

November 14, 2013  


 

Information for marketing authorisation holders

The State Agency of Medicines (hereinafter - SAM) reminds you that the requirements regarding procedure for examination of variations for nationally authorised medicinal products laid down by the Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisation for medicinal products for human use and veterinary medicinal products (hereinafter - Regulation), Chapter IIa “Variations to purely national marketing authorisations” shall come into force on August 4th, 2013. Read more

 

November 13, 2013  


 

Dear clients!

The State Agency of Medicines informs you that due to the end of the financial year no invoices for advance payments will be issued from December 16th, 2013, until December 30th, 2013.

Please take into account that advance payments, where applications for receipt of services will not be submitted until December 2nd, will be returned to the payment maker (if the necessary requisites will have been submitted) or to the marketing authorisation holder.

Our apologies for the inconvenience!

 

November 7, 2013  


 

The State Agency of Medicines organises a meeting of professionals of the European medicines agencies in Riga

The State Agency of Medicines (hereinafter - SAM) organises a meeting for the Working Group of Communication Professionals of the Heads of Medicines Agencies (HMA) network that will take place on 6th-8th of November 2013 in Riga. The meeting will take place under the Lithuanian Presidency of the Council of the European Union to ensure the continuity of the forum operation for field professionals taking into account the capacity of the Medicines Control Agency of Lithuania with regard to organisation of official events. Read more

 

July 19, 2013  


 

Information for marketing authorisation holders

State Agency of Medicines of Latvia (hereinafter - SAM) informs that Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (hereinafter - Regulation), Chapter IIa "Variations to purely national marketing authorisations" requirements regarding variation evaluation procedure for nationally authorised medicinal products will come into effect on August 4th 2013. Read more

 

July 19, 2013  


 

The State Agency of Medicines has considerably improved the Medicinal product register

To ensure that information regarding medicines is quick, easy and simple to find, the State Agency of Medicines (hereinafter - SAM) has improved the Medicinal product register search form that is available on SAM website www.zva.gov.lv. Basing on suggestions from clients several significant improvements have been made - the search procedure of medicines has been simplified and the overview of information regarding selected medicines is more convenient. Read more

 

July 12, 2013  


 

The State Agency of Medicines begins communication on the social microblog website “Twitter”

Starting from today the State Agency of Medicines (hereinafter - SAM) begins communication with the public and cooperation partners on the social microblog website “Twitter” with the user name “@ZVALatvija”. SAM Twitter account followers will be able to follow information regarding news in the pharmaceutical industry, safe use of medicines and SAM general operation.

SAM Director Inguna Adoviča points out that “nowadays modern technologies undeniably provide new opportunities for making everyday operation more efficient. Social networks are one of the ways of using technology to develop closer communication with the public and clients. We are going along with newest developments and the initiation of communication on the social microblog website “Twitter” is just a logical step in order to strengthen collaboration with the public and current clients with the help of faster and more reliable circulation of information.”

With the help of more active use of social networks SAM wishes not only to inform the current clients and the residents who obtain information through traditional mass media, but also address audiences who primarily use newest technologies for communication. The use of social networks will allow to provide information directly and in a timely manner by informing and educating the public about safe use of medicines and medical devices.

SAM also invites residents and clients to join SAM page on the social network website “Facebook” and SAM professional network on “Linkedin”.

 

June 21, 2013  


The State Agency of Medicines has issued the 2012 Statistics on Medicines Consumption

Dear clients!

The State Agency of Medicines has issued the 2012 Statistics on Medicines Consumption

The State Agency of Medicines has issued an electronic version of the "2012 Statistics on Medicines Consumption" providing a thorough insight in the market of medicines. Statistics on medicines consumption is an integral part of the pharmaceutical industry that allows to analyse and supervise the consumption of medicines within the country, as well as adopt decisions to promote rational use of medicines in the country.

The 2012 Statistics on Medicines Consumption is available here.

 

June 21, 2013  


The State Agency of Medicines 2012 annual report

Dear clients!

The State Agency of Medicines publishes 2012 annual report

The State Agency of Medicines has published its 2012 annual report. The report highlights main results of our operation during the previous year, as well as shows the main priorities for the year 2013.

The year 2012 has been as dynamic for the SAM as all the previous years. On the whole this year can be considered as a year of growth and quality. The operation of SAM undoubtedly shows that quality begins within the institution and it is the result of purposeful effort and not merely a coincidence.

The SAM 2012 annual report is available here.

 

April 22, 2013  


 

European Medicines Agency publishes 2012 annual report

The report highlights the main trends recently observed in the Agency’s activities. For the past few years, the Agency has received a stable number of initial marketing-authorisation applications (MAAs) for human medicines, with a total of 96 applications received in 2012. The Committee for Medicinal Products for Human Use (CHMP) issued 59 positive opinions for the approval of new medicines, including a positive opinion for the first gene therapy in Europe.
The European Medicines Agency 2012 annual report is available here.


Archive

2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008

top
@ZVALatvija
Jauna aptauja mūsu mājaslapā: kas ir biozāles jeb bioloģiskas zāles? http://t.co/3UuWOJCoTL
vakar, 11:20
RT @RSUinfo: Medicīnas fakultātes dekāna amatā apstiprināts profesors Guntis Bahs. Īss ieskats MF nākotnē http://t.co/Gj9NVNPMQr http://t.c…
16.04.2014 16:53
@Balzaams Katru šādu gadījumu izskata individuāli, nav noteikta soda, ja rodas šaubas, jāziņo http://t.co/Xj9NBAimrt
15.04.2014 15:52





Last changes made on 22.04.14